wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39267135-CFD29444-DF70-4926-96C0-0234E5FFF5A2
Q39267135-CFD29444-DF70-4926-96C0-0234E5FFF5A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39267135-CFD29444-DF70-4926-96C0-0234E5FFF5A2
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment.
P2860
Q39267135-CFD29444-DF70-4926-96C0-0234E5FFF5A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39267135-CFD29444-DF70-4926-96C0-0234E5FFF5A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
249127cee5e0b4f4c012b2f3ffacdda6535828c5
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies